Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 10,166 | 12,407 | 9,531 | 9,134 | 8,116 |
| Cost of Goods | 5,437 | 7,502 | 4,689 | 5,093 | 5,375 |
| Gross Profit | 4,729 | 4,905 | 4,842 | 4,041 | 2,741 |
| Operating Expenses | 9,372 | 9,836 | 8,188 | 7,417 | 9,178 |
| Operating Income | -4,206 | -4,429 | -2,657 | -3,283 | -6,062 |
| Interest Expense | 433 | 498 | 569 | 582 | 575 |
| Other Income | -120 | -281 | -36 | 3,083 | -204 |
| Pre-tax Income | -4,759 | -5,208 | -3,262 | -782 | -6,841 |
| Income Tax | 17 | 71 | 14 | -80 | 60 |
| Net Income Continuous | -4,776 | -5,279 | -3,276 | -702 | -6,901 |
| Net Income | $-4,776 | $-5,279 | $-3,276 | $-702 | $-6,901 |
| EPS Basic Total Ops | -81.00 | -79.12 | -54.00 | -12.00 | -138.00 |
| EPS Basic Continuous Ops | -77.55 | -80.12 | -53.90 | -11.65 | -128.20 |
| EPS Diluted Total Ops | -81.00 | -79.12 | -54.00 | -12.00 | -138.00 |
| EPS Diluted Continuous Ops | -77.55 | -80.12 | -53.90 | -11.65 | -128.20 |
| EBITDA(a) | $-4,022 | $-4,211 | $-2,413 | $-3,052 | $-5,840 |